|
Market Closed -
Euronext Paris
11:55:00 2026-09-24 EDT
|
After hours 15:59:54 | |||
| 149.10 EUR | +0.68% |
|
150.00 | +0.60% |
| 09-22 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
| 09-22 | European drugmakers call for faster trials, more spending to compete with US, China | RE |
EPS & Dividend: Ipsen
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.535 | 1.532 | 1.655 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 1.03% | 1.03% | 1.11% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 12.02 | 11.75 | 11.68 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 12.8% | 13% | 14.2% |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 149.10 | 149.10 | 149.10 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 2/11/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: Ipsen
| 2026-06-03 | Ex-dividend date - 1.6 EUR | 00:00 |
Upcoming Events: Ipsen
| 2026-09-30 | Information meeting | Day | |
| 2026-10-21 | Sales and Revenue Release | Q3 2026 | Day |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 1.04% | 1.03% | 12.32x | 2.38x | 2.4x | |
| 0.6% | 0.67% | 32.72x | 20.8x | 11.87x | |
| 2% | 2.09% | 29.94x | - | 6.66x | |
| 2.59% | 2.72% | 33.52x | -482.73x | 7.84x | |
| 2.76% | 2.82% | 19.75x | 7.22x | 4.81x | |
| 3.05% | 3.19% | 20.12x | 5.72x | 5.24x | |
| 2.03% | 2.15% | 21.01x | 4.73x | 4.36x | |
| 2.48% | 2.62% | 25.68x | 19.4x | 6.7x | |
| 2.17% | 2.21% | -45.78x | 11.27x | 6.66x | |
| 4.45% | 4.46% | 11.29x | 4.76x | 4.12x | |
| Average | 2.32% | 2.4% | 16.06x | -45.16x | 6.07x | |
| Weighted average by Cap. | 1.98% | 2.07% | 23.70x | -64.86x | 7.71x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
